Back to search

Belgium· BE-AMP-SAM662288-00

Tardysol 20 mg/ml

A ferrous sulfate product containing ferrous sulfate heptahydrate, registered in Belgium by Pierre Fabre Médicament. The same ATC class is registered in 10 of our 19 countries.

ATC B03AA07

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedTardysol 20 mg/mlATCB03AA07REGISTER NO.BE-AMP-SAM662288-00PACKS LISTED1CHECKEDSeptember 26, 2026

Where it is registered

Ferrous sulfate is registered in 10 of 19 countries.

Countries holding a registration under ATC B03AA07 (ferrous sulfate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 7 of them publish a price we can compare per daily dose

Ferrous sulfate · ATC B03AA07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous sulfate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ferrous sulfate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.77
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Ferrous Sulfate Heptahydrate
Manufacturer
Pierre Fabre Médicament
Country
Belgium (BE)
ATC code
B03AA07
ATC class
Ferrous sulfate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 1

  • be_apb
    4822177

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for ferrous sulfate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ferrous sulfate · interactions on record

80 records

  • 3 severe
  • 68 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ferrous sulfate in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ferrous sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Ferro - Gradumet
  • Germany · Eisensulfat Lomapharm, Ferro Aiwa
  • Spain · Ferogradumet
  • France · Fer Nouveau-Ne Ap-Hp
  • United Kingdom (Northern Ireland) · Feospan, Ferrous Sulfate Wockhardt Uk
  • Greece · Tardyferon
  • Hungary · Ferro-Gradumet
  • Lithuania · Tardyferon
  • Luxembourg · Fero-Gradumet
  • Norway · Duroferon, Ferromax
  • Portugal · Ferro-Gradumet
  • Slovakia · Tardyferon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c5d4e5d2-092a-49ec-9ee7-52ef2572d57d
GET /v1/drugs/c5d4e5d2-092a-49ec-9ee7-52ef2572d57d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oral solution",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Tardysol 20 mg/ml",
  "name_fr": "Tardysol 20 mg/ml",
  "name_nl": "Tardysol 20 mg/ml",
  "amp_code": "SAM662288-00",
  "strengths": [
    "99.5600",
    "99.5600",
    "20.0000",
    "20.0000",
    "2.0000",
    "1.5000",
    "500.0000"
  ],
  "pack_count": 1,
  "substances": [
    "Ferrous Sulfate Heptahydrate",
    "Iron",
    "Saccharin Sodium",
    "Sodium Propionate",
    "Sorbitol Liquid Non-Crystallising"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Ferrous Sulfate",
  "authorisation_numbers": [
    "BE662288"
  ]
}

See everything about ferrous sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.